img

Global Acute Myeloid Leukemia Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acute Myeloid Leukemia Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.
Acute Myeloid Leukemia Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acute Myeloid Leukemia Drugs market is projected to reach US$ 3463.7 million in 2029, increasing from US$ 1758 million in 2022, with the CAGR of 10.2% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The Acute Myeloid Leukemia (AML) Drugs market driver is the increasing incidence of AML globally, leading to a growing demand for effective treatments. The introduction of novel targeted therapies and immunotherapies has also driven market growth. However, challenges include the complexity of AML genetics, the need for personalized treatment approaches, and the high cost of newer therapies. Additionally, the competitive landscape and stringent regulatory requirements pose challenges for market players. Despite challenges, the AML Drugs market presents potential for growth as researchers and pharmaceutical companies continue to explore innovative treatments for this aggressive hematologic malignancy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acute Myeloid Leukemia Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ambit Biosciences Corporation
Bristol Myers Squibb
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Novartis
Eli Lilly and Company
Otsuka Holdings
Takeda Pharmaceuticals
Segment by Type
Chemotherapy
Targeted Therapy
Other

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acute Myeloid Leukemia Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acute Myeloid Leukemia Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acute Myeloid Leukemia Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Acute Myeloid Leukemia Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acute Myeloid Leukemia Drugs introduction, etc. Acute Myeloid Leukemia Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Acute Myeloid Leukemia Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Acute Myeloid Leukemia Drugs Market Overview
1.1 Acute Myeloid Leukemia Drugs Product Overview
1.2 Acute Myeloid Leukemia Drugs Market Segment by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Other
1.3 Global Acute Myeloid Leukemia Drugs Market Size by Type
1.3.1 Global Acute Myeloid Leukemia Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Acute Myeloid Leukemia Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Acute Myeloid Leukemia Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Acute Myeloid Leukemia Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Acute Myeloid Leukemia Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Acute Myeloid Leukemia Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Acute Myeloid Leukemia Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Acute Myeloid Leukemia Drugs Sales Breakdown by Type (2018-2024)
2 Global Acute Myeloid Leukemia Drugs Market Competition by Company
2.1 Global Top Players by Acute Myeloid Leukemia Drugs Sales (2018-2024)
2.2 Global Top Players by Acute Myeloid Leukemia Drugs Revenue (2018-2024)
2.3 Global Top Players by Acute Myeloid Leukemia Drugs Price (2018-2024)
2.4 Global Top Manufacturers Acute Myeloid Leukemia Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Acute Myeloid Leukemia Drugs Market Competitive Situation and Trends
2.5.1 Acute Myeloid Leukemia Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Acute Myeloid Leukemia Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Acute Myeloid Leukemia Drugs Market
2.8 Key Manufacturers Acute Myeloid Leukemia Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Acute Myeloid Leukemia Drugs Status and Outlook by Region
3.1 Global Acute Myeloid Leukemia Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Acute Myeloid Leukemia Drugs Historic Market Size by Region
3.2.1 Global Acute Myeloid Leukemia Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Acute Myeloid Leukemia Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Acute Myeloid Leukemia Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Acute Myeloid Leukemia Drugs Forecasted Market Size by Region
3.3.1 Global Acute Myeloid Leukemia Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Acute Myeloid Leukemia Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Acute Myeloid Leukemia Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Acute Myeloid Leukemia Drugs by Application
4.1 Acute Myeloid Leukemia Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Acute Myeloid Leukemia Drugs Market Size by Application
4.2.1 Global Acute Myeloid Leukemia Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Acute Myeloid Leukemia Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Acute Myeloid Leukemia Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Acute Myeloid Leukemia Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Acute Myeloid Leukemia Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Acute Myeloid Leukemia Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Acute Myeloid Leukemia Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Acute Myeloid Leukemia Drugs Sales Breakdown by Application (2018-2024)
5 North America Acute Myeloid Leukemia Drugs by Country
5.1 North America Acute Myeloid Leukemia Drugs Historic Market Size by Country
5.1.1 North America Acute Myeloid Leukemia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Acute Myeloid Leukemia Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Acute Myeloid Leukemia Drugs Sales in Value by Country (2018-2024)
5.2 North America Acute Myeloid Leukemia Drugs Forecasted Market Size by Country
5.2.1 North America Acute Myeloid Leukemia Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Acute Myeloid Leukemia Drugs Sales in Value by Country (2024-2029)
6 Europe Acute Myeloid Leukemia Drugs by Country
6.1 Europe Acute Myeloid Leukemia Drugs Historic Market Size by Country
6.1.1 Europe Acute Myeloid Leukemia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Acute Myeloid Leukemia Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Acute Myeloid Leukemia Drugs Sales in Value by Country (2018-2024)
6.2 Europe Acute Myeloid Leukemia Drugs Forecasted Market Size by Country
6.2.1 Europe Acute Myeloid Leukemia Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Acute Myeloid Leukemia Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Acute Myeloid Leukemia Drugs by Region
7.1 Asia-Pacific Acute Myeloid Leukemia Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Acute Myeloid Leukemia Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Acute Myeloid Leukemia Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Acute Myeloid Leukemia Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Acute Myeloid Leukemia Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Acute Myeloid Leukemia Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Acute Myeloid Leukemia Drugs Sales in Value by Region (2024-2029)
8 Latin America Acute Myeloid Leukemia Drugs by Country
8.1 Latin America Acute Myeloid Leukemia Drugs Historic Market Size by Country
8.1.1 Latin America Acute Myeloid Leukemia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Acute Myeloid Leukemia Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Acute Myeloid Leukemia Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Acute Myeloid Leukemia Drugs Forecasted Market Size by Country
8.2.1 Latin America Acute Myeloid Leukemia Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Acute Myeloid Leukemia Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Acute Myeloid Leukemia Drugs by Country
9.1 Middle East and Africa Acute Myeloid Leukemia Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Acute Myeloid Leukemia Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Acute Myeloid Leukemia Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Acute Myeloid Leukemia Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Acute Myeloid Leukemia Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Acute Myeloid Leukemia Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Acute Myeloid Leukemia Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ambit Biosciences Corporation
10.1.1 Ambit Biosciences Corporation Company Information
10.1.2 Ambit Biosciences Corporation Introduction and Business Overview
10.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Products Offered
10.1.5 Ambit Biosciences Corporation Recent Development
10.2 Bristol Myers Squibb
10.2.1 Bristol Myers Squibb Company Information
10.2.2 Bristol Myers Squibb Introduction and Business Overview
10.2.3 Bristol Myers Squibb Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol Myers Squibb Acute Myeloid Leukemia Drugs Products Offered
10.2.5 Bristol Myers Squibb Recent Development
10.3 Cephalon
10.3.1 Cephalon Company Information
10.3.2 Cephalon Introduction and Business Overview
10.3.3 Cephalon Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Cephalon Acute Myeloid Leukemia Drugs Products Offered
10.3.5 Cephalon Recent Development
10.4 Clavis Pharma
10.4.1 Clavis Pharma Company Information
10.4.2 Clavis Pharma Introduction and Business Overview
10.4.3 Clavis Pharma Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Clavis Pharma Acute Myeloid Leukemia Drugs Products Offered
10.4.5 Clavis Pharma Recent Development
10.5 Eisai
10.5.1 Eisai Company Information
10.5.2 Eisai Introduction and Business Overview
10.5.3 Eisai Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eisai Acute Myeloid Leukemia Drugs Products Offered
10.5.5 Eisai Recent Development
10.6 Genzyme Corporation
10.6.1 Genzyme Corporation Company Information
10.6.2 Genzyme Corporation Introduction and Business Overview
10.6.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Genzyme Corporation Acute Myeloid Leukemia Drugs Products Offered
10.6.5 Genzyme Corporation Recent Development
10.7 Sunesis Pharmaceuticals
10.7.1 Sunesis Pharmaceuticals Company Information
10.7.2 Sunesis Pharmaceuticals Introduction and Business Overview
10.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Products Offered
10.7.5 Sunesis Pharmaceuticals Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novartis Acute Myeloid Leukemia Drugs Products Offered
10.8.5 Novartis Recent Development
10.9 Eli Lilly and Company
10.9.1 Eli Lilly and Company Company Information
10.9.2 Eli Lilly and Company Introduction and Business Overview
10.9.3 Eli Lilly and Company Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly and Company Acute Myeloid Leukemia Drugs Products Offered
10.9.5 Eli Lilly and Company Recent Development
10.10 Otsuka Holdings
10.10.1 Otsuka Holdings Company Information
10.10.2 Otsuka Holdings Introduction and Business Overview
10.10.3 Otsuka Holdings Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Otsuka Holdings Acute Myeloid Leukemia Drugs Products Offered
10.10.5 Otsuka Holdings Recent Development
10.11 Takeda Pharmaceuticals
10.11.1 Takeda Pharmaceuticals Company Information
10.11.2 Takeda Pharmaceuticals Introduction and Business Overview
10.11.3 Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Products Offered
10.11.5 Takeda Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Acute Myeloid Leukemia Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Acute Myeloid Leukemia Drugs Industrial Chain Analysis
11.4 Acute Myeloid Leukemia Drugs Market Dynamics
11.4.1 Acute Myeloid Leukemia Drugs Industry Trends
11.4.2 Acute Myeloid Leukemia Drugs Market Drivers
11.4.3 Acute Myeloid Leukemia Drugs Market Challenges
11.4.4 Acute Myeloid Leukemia Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Acute Myeloid Leukemia Drugs Distributors
12.3 Acute Myeloid Leukemia Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Chemotherapy
Table 2. Major Company of Targeted Therapy
Table 3. Major Company of Other
Table 4. Global Acute Myeloid Leukemia Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (K Units)
Table 6. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (US& Million)
Table 8. Global Acute Myeloid Leukemia Drugs Market Share in Value by Type (2018-2024)
Table 9. Global Acute Myeloid Leukemia Drugs Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Acute Myeloid Leukemia Drugs Sales by Type (2024-2029) & (K Units)
Table 11. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Acute Myeloid Leukemia Drugs Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type (2024-2029)
Table 14. Global Acute Myeloid Leukemia Drugs Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (K Units)
Table 16. North America Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Acute Myeloid Leukemia Drugs Sales (K Units) by Type (2018-2024)
Table 18. Europe Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Acute Myeloid Leukemia Drugs Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Acute Myeloid Leukemia Drugs Sales (K Units) by Type (2018-2024)
Table 22. Latin America Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Acute Myeloid Leukemia Drugs Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Acute Myeloid Leukemia Drugs Sales by Company (2018-2024) & (K Units)
Table 26. Global Acute Myeloid Leukemia Drugs Sales Share by Company (2018-2024)
Table 27. Global Acute Myeloid Leukemia Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Acute Myeloid Leukemia Drugs Revenue Share by Company (2018-2024)
Table 29. Global Market Acute Myeloid Leukemia Drugs Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Acute Myeloid Leukemia Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Acute Myeloid Leukemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Acute Myeloid Leukemia Drugs Market
Table 34. Key Manufacturers Acute Myeloid Leukemia Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Acute Myeloid Leukemia Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Acute Myeloid Leukemia Drugs Sales by Region (2018-2024) & (K Units)
Table 38. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Acute Myeloid Leukemia Drugs Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Region (2018-2024)
Table 41. Global Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Acute Myeloid Leukemia Drugs Sales by Region (2024-2029) & (K Units)
Table 43. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Acute Myeloid Leukemia Drugs Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Region (2024-2029)
Table 46. Global Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Acute Myeloid Leukemia Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (K Units)
Table 49. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application (2018-2024)
Table 52. Global Acute Myeloid Leukemia Drugs Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Acute Myeloid Leukemia Drugs Sales by Application (2024-2029) & (K Units)
Table 54. Global Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Acute Myeloid Leukemia Drugs Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application (2024-2029)
Table 57. Global Acute Myeloid Leukemia Drugs Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) (K Units)
Table 59. North America Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) (K Units)
Table 61. Europe Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) (K Units)
Table 65. Latin America Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (K Units)
Table 69. North America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2018-2024)
Table 72. North America Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (K Units)
Table 73. North America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (K Units)
Table 77. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (K Units)
Table 81. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Acute Myeloid Leukemia Drugs Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Value by Country (2024-2029)
Table 108. Ambit Biosciences Corporation Company Information
Table 109. Ambit Biosciences Corporation Introduction and Business Overview
Table 110. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product
Table 112. Ambit Biosciences Corporation Recent Development
Table 113. Bristol Myers Squibb Company Information
Table 114. Bristol Myers Squibb Introduction and Business Overview
Table 115. Bristol Myers Squibb Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Bristol Myers Squibb Acute Myeloid Leukemia Drugs Product
Table 117. Bristol Myers Squibb Recent Development
Table 118. Cephalon Company Information
Table 119. Cephalon Introduction and Business Overview
Table 120. Cephalon Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Cephalon Acute Myeloid Leukemia Drugs Product
Table 122. Cephalon Recent Development
Table 123. Clavis Pharma Company Information
Table 124. Clavis Pharma Introduction and Business Overview
Table 125. Clavis Pharma Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Clavis Pharma Acute Myeloid Leukemia Drugs Product
Table 127. Clavis Pharma Recent Development
Table 128. Eisai Company Information
Table 129. Eisai Introduction and Business Overview
Table 130. Eisai Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Eisai Acute Myeloid Leukemia Drugs Product
Table 132. Eisai Recent Development
Table 133. Genzyme Corporation Company Information
Table 134. Genzyme Corporation Introduction and Business Overview
Table 135. Genzyme Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Genzyme Corporation Acute Myeloid Leukemia Drugs Product
Table 137. Genzyme Corporation Recent Development
Table 138. Sunesis Pharmaceuticals Company Information
Table 139. Sunesis Pharmaceuticals Introduction and Business Overview
Table 140. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product
Table 142. Sunesis Pharmaceuticals Recent Development
Table 143. Novartis Company Information
Table 144. Novartis Introduction and Business Overview
Table 145. Novartis Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Novartis Acute Myeloid Leukemia Drugs Product
Table 147. Novartis Recent Development
Table 148. Eli Lilly and Company Company Information
Table 149. Eli Lilly and Company Introduction and Business Overview
Table 150. Eli Lilly and Company Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Eli Lilly and Company Acute Myeloid Leukemia Drugs Product
Table 152. Eli Lilly and Company Recent Development
Table 153. Otsuka Holdings Company Information
Table 154. Otsuka Holdings Introduction and Business Overview
Table 155. Otsuka Holdings Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Otsuka Holdings Acute Myeloid Leukemia Drugs Product
Table 157. Otsuka Holdings Recent Development
Table 158. Takeda Pharmaceuticals Company Information
Table 159. Takeda Pharmaceuticals Introduction and Business Overview
Table 160. Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Product
Table 162. Takeda Pharmaceuticals Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Acute Myeloid Leukemia Drugs Market Trends
Table 166. Acute Myeloid Leukemia Drugs Market Drivers
Table 167. Acute Myeloid Leukemia Drugs Market Challenges
Table 168. Acute Myeloid Leukemia Drugs Market Restraints
Table 169. Acute Myeloid Leukemia Drugs Distributors List
Table 170. Acute Myeloid Leukemia Drugs Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Myeloid Leukemia Drugs Product Picture
Figure 2. Global Acute Myeloid Leukemia Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Acute Myeloid Leukemia Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Acute Myeloid Leukemia Drugs Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Chemotherapy
Figure 6. Global Chemotherapy Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Targeted Therapy
Figure 8. Global Targeted Therapy Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Acute Myeloid Leukemia Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Acute Myeloid Leukemia Drugs Sales Market Share by Type in 2022 & 2029
Figure 13. North America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Myeloid Leukemia Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Myeloid Leukemia Drugs Revenue in 2022
Figure 25. Acute Myeloid Leukemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Acute Myeloid Leukemia Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Acute Myeloid Leukemia Drugs Sales Market Share by Application in 2022 & 2029
Figure 34. North America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Acute Myeloid Leukemia Drugs Manufacturing Cost Structure
Figure 45. Acute Myeloid Leukemia Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed